Case A. - 42 yr old male patient

16
Treatment of Extra-intestinal Manifestations of IBD: Case studies Alan C. Moss MD, FEBG, FACG Associate Professor of Medicine Director of Translational Research

description

Treatment of Extra-intestinal Manifestations of IBD: Case studies Alan C. Moss MD, FEBG, FACG Associate Professor of Medicine Director of Translational Research. Case A. - 42 yr old male patient. Left-sided ulcerative colitis for 4 years In clinical remission on mesalamine 4.8g/day - PowerPoint PPT Presentation

Transcript of Case A. - 42 yr old male patient

Page 1: Case A. - 42 yr old male patient

Treatment of Extra-intestinal Manifestations of IBD: Case studies

Alan C. Moss MD, FEBG, FACG

Associate Professor of MedicineDirector of Translational Research

Page 2: Case A. - 42 yr old male patient

Case A. - 42 yr old male patient

• Left-sided ulcerative colitis for 4 years• In clinical remission on mesalamine 4.8g/day

• Admitted for flare-up January 2013 – Rx IV steroids and discharged on PO prednisone taper

• Clinic follow-up – slow to taper off prednisone, azathioprine added, tolerated well

• Seen in office visit complaining of fatigue; started on oral ferrous sulfate 100mg by primary care physician

Page 3: Case A. - 42 yr old male patient

Trend in Hematologic Indices

Hematocrit (40-50%) Iron Profile

Page 4: Case A. - 42 yr old male patient

What would you do next?

A. Increase oral iron dose

B. Blood transfusion

C. Iron infusion

D. Erythropoietin

E. All of the above

Page 5: Case A. - 42 yr old male patient

Causes of Anemia in IBD

Iron Deficiency Chronic

Disease

Bone marrow suppressionDrug-induced hemolysis

Vitamin B12 / folic acid deficiency

Gisbert J, Am J Gastroenterol. 2008 May;103(5):1299-307.

20% of Out-patients60% of Hospitalized patients

Page 6: Case A. - 42 yr old male patient

Determining Iron Deficiency in IBD

Gasche C, Inflamm Bowel Dis 2007;13:1545-1553

Page 7: Case A. - 42 yr old male patient

Oral OR IV Iron for Iron Deficiency in IBD

Study Comparisons

Reinisch 2013 PO FeSO4 200mg v IV iron isomaltoside

Schroder 2005 PO FeSO4 200mg v IV iron sucrose

Gisbert 2009 PO FeSO4 v IV iron sucrose

Lindgren S 2009 PO FeSO4 v IV iron sucrose

Kulnigg 2008 PO FeSO4 200mg v IV ferric carboxymaltose

Page 8: Case A. - 42 yr old male patient

Meta-Analysis of Trials to Date

• Hb rise >2g/dl - RR of 0.98, 95% (CI 0.9, 1.1) p=0.7• Mean change in Hb (g/dl) - 0.7 96% (CI 0.3, 1.7) p=0.1

• Increase in serum ferritin - 84, 95% (CI 79, 92) p>0.001

• Risk of withdrawal due to adverse events RR 2.7 (CI 1.4, 5.2) p=0.002

Abhyankar, Moss submitted to DDW 2014

Page 9: Case A. - 42 yr old male patient

Erythropoietin for Anemia in IBD

Schreiber s N Engl J Med. 1996 Mar 7;334(10):619-23

Page 10: Case A. - 42 yr old male patient

Guidelines – ECCO 2013

• “Iron supplementation should be initiated when iron deficiency anemia is present, and considered when there is iron deficiency without anemia

• Intravenous iron is more effective and better tolerated than oral iron supplements

• Absolute indications for intravenous iron include severe anemia (hemoglobin < 10.0 g/dL), and intolerance or inadequate response to oral iron

• Intravenous iron should be considered in combination with an erythropoietic agent in selected cases where a rapid response is required”

Van Asche G, J Crohns Colitis. 2013 Feb;7(1):1-33

Page 11: Case A. - 42 yr old male patient

Case B. - 59 year old male

• Colonic Crohn’s for 20 years• Developed lymphoma while on azathioprine

• Recent flare-up; 4-6 BM per day, cramps• Rx budesonide & metronidazole

• Call from PCP – in local ED with frank rectal bleeding, and swollen left leg

• Ultrasound – left leg Deep Venous Thrombosis (DVT)

Page 12: Case A. - 42 yr old male patient

Sigmoidoscopy

Page 13: Case A. - 42 yr old male patient

What would you suggest next?

A. Low Molecular Weight Heparin

B. Unfractionated Heparin

C. Vena caval filter

D. Other

Page 14: Case A. - 42 yr old male patient

Venous Thromboembolism in IBD – A ‘Preventable Complication’

• 1-2% of all IBD hospitalizations

• Out-patients have 8-fold higher risk of VTE during flares, than when in remission

• Risks: age, UC, surgery, smoking, oral contraceptives

• Less than 40% of GIs ‘always’ prescribe VTE prophylaxis

Nyugen G. Am J Gastroenterol. 2008 Sep;103(9):2272-80; Grainge MJ, Lancet. 2010 Feb 20;375(9715):657-63

Razik R, Can J Gastroenterol. 2012 Nov;26(11):795-8

Page 15: Case A. - 42 yr old male patient

VTE Prophylaxis is Under-Utilized in IBD

Pleet J et al , DDW 2013, S434

Number of hospital days with VTE prophylaxis ordered

‘None’‘All’

Actual administration of ordered doses by nurses

Page 16: Case A. - 42 yr old male patient

VTE Prevention in IBD

• AGA Physician Performance Measures Set 2011;

‘Measure # 9: Patients with IBD receive prophylaxis for venous thromboembolism during hospitalization for any reason.’

• LMW / UF heparin• Compression stockings• Minimizing IV catheter use• Address smoking, OCP use, immobility

• ?Out-patient flares also